These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7657286)

  • 21. Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis.
    Escorsell A; Feu F; Bordas JM; García-Pagán JC; Luca A; Bosch J; Rodés J
    J Hepatol; 1996 Apr; 24(4):423-9. PubMed ID: 8738728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duplex Doppler ultrasonography allows a multiorgan noninvasive approach to splanchnic pharmacodynamics in patients with cirrhosis.
    Bolognesi M; Sacerdoti D; Merkel C; Caregaro L; Bellon S; Gatta A
    Bildgebung; 1995 Jun; 62(2):138-43. PubMed ID: 7663138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
    Vorobioff J; Picabea E; Gamen M; Villavicencio R; Bordato J; Bessone F; Tanno H; Palazzi J; Sarano H; Pozzoli L
    Hepatology; 1993 Sep; 18(3):477-84. PubMed ID: 8359793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients.
    Sarin SK; Wadhawan M; Gupta R; Shahi H
    Dig Dis Sci; 2005 Aug; 50(8):1538-47. PubMed ID: 16110851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Doppler sonography and hepatic vein catheterization in portal hypertension: assessment of agreement in evaluating severity and response to treatment.
    Merkel C; Sacerdoti D; Bolognesi M; Bombonato G; Gatta A
    J Hepatol; 1998 Apr; 28(4):622-30. PubMed ID: 9566831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT.
    García-Pagán JC; Morillas R; Bañares R; Albillos A; Villanueva C; Vila C; Genescà J; Jimenez M; Rodriguez M; Calleja JL; Balanzó J; García-Durán F; Planas R; Bosch J;
    Hepatology; 2003 Jun; 37(6):1260-6. PubMed ID: 12774003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined therapies versus monotherapies for the first variceal bleeding in patients with high-risk varices: a meta-analysis of randomized controlled trials.
    Bai M; Qi X; Yang M; Han G; Fan D
    J Gastroenterol Hepatol; 2014 Mar; 29(3):442-52. PubMed ID: 24118091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.
    Sauerbruch T; Mengel M; Dollinger M; Zipprich A; Rössle M; Panther E; Wiest R; Caca K; Hoffmeister A; Lutz H; Schoo R; Lorenzen H; Trebicka J; Appenrodt B; Schepke M; Fimmers R;
    Gastroenterology; 2015 Sep; 149(3):660-8.e1. PubMed ID: 25989386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatostatin plus isosorbide 5-mononitrate versus somatostatin in the control of acute gastro-oesophageal variceal bleeding: a double blind, randomised, placebo controlled clinical trial.
    Junquera F; López-Talavera JC; Mearin F; Saperas E; Videla S; Armengol JR; Esteban R; Malagelada JR
    Gut; 2000 Jan; 46(1):127-32. PubMed ID: 10601068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding.
    Lo GH; Chen WC; Lin CK; Tsai WL; Chan HH; Chen TA; Yu HC; Hsu PI; Lai KH
    Hepatology; 2008 Aug; 48(2):580-7. PubMed ID: 18666235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of cirrhosis and ascites.
    Bhaskar ME
    N Engl J Med; 2004 Jul; 351(3):300-1; author reply 300-1. PubMed ID: 15257569
    [No Abstract]   [Full Text] [Related]  

  • 32. Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding.
    Laleman W; Nevens F
    Minerva Med; 2006 Aug; 97(4):325-45. PubMed ID: 17008837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, controlled trial of banding ligation plus drug therapy versus drug therapy alone in the prevention of esophageal variceal rebleeding.
    Lo GH; Chen WC; Chan HH; Tsai WL; Hsu PI; Lin CK; Chen TA; Lai KH
    J Gastroenterol Hepatol; 2009 Jun; 24(6):982-7. PubMed ID: 19638080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Isosorbide-5-mononitrate (mono mac) in the prevention of bleeding from esophageal varicose veins in patients with liver cirrhosis].
    Abdurakhmanov DT
    Klin Med (Mosk); 2001; 79(2):60-2. PubMed ID: 11419092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of 5-isosorbide mononitrate and propranolol on subclinical hepatic encephalopathy and renal function in patients with liver cirrhosis.
    Silva G; Segovia R; Ponce R; Backhouse C; Palma M; Roblero JP; Abadal J; Quijada C; Troncoso M; Iturriaga H
    Hepatogastroenterology; 2002; 49(47):1357-62. PubMed ID: 12239942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.
    García-Pagán JC; Feu F; Bosch J; Rodés J
    Ann Intern Med; 1991 May; 114(10):869-73. PubMed ID: 2014947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive beta-blockers.
    García-Pagán JC; Villanueva C; Vila MC; Albillos A; Genescà J; Ruiz-Del-Arbol L; Planas R; Rodriguez M; Calleja JL; González A; Solà R; Balanzó J; Bosch J;
    Gastroenterology; 2001 Oct; 121(4):908-14. PubMed ID: 11606504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Should nitrates be used with beta blockers to prevent variceal bleeding?
    Zalepuga R; Herrera JL
    Am J Gastroenterol; 2000 Oct; 95(10):2982-3. PubMed ID: 11051383
    [No Abstract]   [Full Text] [Related]  

  • 39. Renal effects of acute isosorbide-5-mononitrate administration in cirrhosis.
    Salmerón JM; Ruiz del Arbol L; Ginès A; García-Pagán JC; Ginès P; Feu F; Claria J; Rivera F; Bosch J; Arroyo V
    Hepatology; 1993 May; 17(5):800-6. PubMed ID: 8491447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nadolol for prevention of variceal rebleeding in cirrhosis: a controlled clinical trial.
    Gatta A; Merkel C; Sacerdoti D; Bolognesi M; Caregaro L; Zuin R; Angeli P; Ruol A
    Digestion; 1987; 37(1):22-8. PubMed ID: 3301478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.